The study will determine the efficacy of the cells to treat rotator cuff tears necessitating arthroscopic repair.
Pluristem has also announced that PLX-PAD cells are intended to grow the company’s presence in the sports medicine and orthopedic markets.
More Articles on Sports Medicine:
Manhattan Orthopedic Care Releases NBA Injury Infographic
Drs. Robert Zura, Claude Moorman Perform Successful Surgery on Duke’s Seth Curry
Methodist Willowbrook Hospital Opens Sports Medicine Center
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.